Emodin ameliorates diabetic cardiomyopathy by regulating mitochondrial dynamics of fission and fusion and ferroptosis through the AHR‑Nrf2 pathway.
Emodin, a natural anthraquinone with known antioxidant properties, has not been fully investigated in diabetic cardiomyopathy (DCM), a condition marked by oxidative stress, ferroptosis and metabolic disturbance, and lacking specific therapies. A DCM model was induced by streptozotocin and a high‑fat diet. Cardiac funct...